全球填充饰面製造市场规模、份额和成长分析：按类型、按应用分类 - 产业预测（2023-2030）

Global Fill Finish Manufacturing Market Size, Share, Growth Analysis, By Type(Consumables and Instruments), By Application(Oncology and Infectious Diseases, Autoimmune Diseases and Others.) - Industry Forecast 2023-20300

出版日期: 2023年10月07日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2021 年全球填充涂料製造市场规模为 83 亿美元，到 2030 年将从 2022 年的 92.7 亿美元增至 224.7 亿美元，年复合成长率预计为 11.7%。

近年来市场呈现稳定成长态势。这可归因于生物製药需求增加、慢性病流行以及对先进药物输送系统的需求等因素。此外，不断增长的老年人口和对个人化医疗日益增长的兴趣正在推动对填充製造服务的需求。西林瓶、注射器、药筒和安瓿等消耗品占据了很大的市场。预充式註射器的日益普及和对创新包装解决方案的需求正在推动灌装製造中消耗品的成长。同时，灌装机、封盖机和检测系统等用于填充製造的设备正在显示出技术进步，以提高效率并减少人为错误。这些製程的自动化提高了准确性、降低了污染风险并加快了生产速度。

全球填充饰面製造市场动态

全球填充饰面製造市场的驱动因素

生物技术产业的成长

专注于开发创新个体化药物的生物技术部门的扩张是市场的主要驱动力。该行业需要先进的灌装加工流程来有效包装和运输复杂且敏感的生物产品，为市场创造巨大的成长机会。

全球填充涂料製造市场的抑制因素

对产品污染的担忧

在製药生产中，保持产品完整性并防止填充过程中的污染至关重要。产品污染或品质问题可能会产生严重影响，包括产品召回和品牌声誉受损。这对填充饰面製造市场提出了挑战，必须实施严格的品管措施，并且必须有效解决和减轻污染风险。

全球填充饰面製造的主要市场趋势

主要市场趋势之一是越来越多地采用先进技术和自动化。近年来，已经出现了使用自动化系统和先进技术来提高灌装-加工流程的效率、准确性和合规性的重大转变。

本报告研究和分析了全球填充饰面製造市场，提供市场动态和前景、细分市场分析、公司简介等。

Pfizer Inc. (US)
F. Hoffmann-La Roche Ltd. (Switzerland)
Novartis AG (Switzerland)
Sanofi SA (France)
Johnson & Johnson Services, Inc. (US)
Eli Lilly and Company (US)
AstraZeneca PLC (United Kingdom)
Merck & Co., Inc. (US)
GlaxoSmithKline plc (United Kingdom)
Boehringer Ingelheim GmbH (Germany)
Novo Nordisk A/S (Denmark)
Bristol Myers Squibb Company (US)
AbbVie Inc. (US)
Amgen Inc. (US)
Takeda Pharmaceutical Company Limited (Japan)
Biogen Inc. (US)
Gilead Sciences, Inc. (US)
Celgene Corporation (US)
Mylan NV (US)
Teva Pharmaceutical Industries Ltd. (Israel)

简介目录

Product Code: SQMIG35H2111

The Global Fill Finish Manufacturing Market size was valued at USD 8.3 billion in 2021 and is poised to grow from USD 9.27 billion in 2022 to USD 22.47 billion by 2030, growing at a CAGR of 11.7% in the forecast period (2023-2030).

The global fill finish manufacturing market has been experiencing steady growth in recent years. This can be attributed to factors such as the increasing demand for biopharmaceuticals, rising prevalence of chronic diseases, and the need for advanced drug delivery systems. Additionally, the expanding aging population and the growing focus on personalized medicine are driving the demand for fill finish manufacturing services. Consumables, such as vials, syringes, cartridges, and ampoules, account for a significant share of the market. The increasing adoption of prefilled syringes and the demand for innovative packaging solutions are propelling the growth of consumables in fill finish manufacturing. On the other hand, instruments used in fill finish manufacturing, such as filling machines, capping machines, and inspection systems, are witnessing technological advancements to improve efficiency and reduce human errors. The automation of these processes is gaining traction, leading to improved accuracy, reduced contamination risks, and increased production rates.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Emergency Lighting Systems Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Fill Finish Manufacturing Market Segmental Analysis

The Global Fill Finish Manufacturing Market is segmented by type, application, and region. Based on type, the market can be segmented into Consumables and Instruments. Based on application, the market is segmented into Oncology and Infectious Diseases, Autoimmune Diseases and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Fill Finish Manufacturing Market Dynamics

Drivers of the Global Fill Finish Manufacturing Market

Growing Biotechnology Industry

The expanding biotechnology sector, which focuses on the development of innovative and personalized medicines, is a key driver for the fill finish manufacturing market. This industry demands advanced fill finish processes to effectively package and deliver complex and sensitive biologic products, creating significant growth opportunities for the market.

Restraints in the Global Fill Finish Manufacturing Market

Concerns Regarding Product Contamination

Maintaining the integrity of products and preventing contamination during the fill finish process is of utmost importance in pharmaceutical manufacturing. Instances of product contamination or quality issues can have severe repercussions, including product recalls and damage to brand reputation. This necessitates the implementation of stringent quality control measures and poses challenges for the fill finish manufacturing market, which must address and mitigate the risk of contamination effectively.

Market Trends of Global Fill Finish Manufacturing Key

One key market trend in the global fill finish manufacturing market is the increasing adoption of advanced technologies and automation. Fill finish manufacturing refers to the final stages of the pharmaceutical production process, where the drug product is filled into vials, syringes, or other containers and then sealed and labeled. In recent years, there has been a significant shift towards the use of automated systems and advanced technologies to improve efficiency, precision, and compliance in the fill finish process.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
- Regulatory Landscape
- Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global Fill Finish Manufacturing Market by Type
- Market Overview
- Consumables and Instruments
Global Fill Finish Manufacturing Market by Application
- Market Overview
- Oncology and Infectious Diseases
- Autoimmune Diseases and Others.
Global Fill Finish Manufacturing Market Size by Region
- Market Overview
- North America
USA
Canada
- Europe
Germany
Spain
France
UK
Rest of Europe
- Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
- Latin America
Brazil
Rest of Latin America
- Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
By Development
By Company
By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Pfizer Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- F. Hoffmann-La Roche Ltd. (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Novartis AG (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Sanofi S.A. (France)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Johnson & Johnson Services, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Eli Lilly and Company (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- AstraZeneca PLC (United Kingdom)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Merck & Co., Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- GlaxoSmithKline plc (United Kingdom)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Boehringer Ingelheim GmbH (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Novo Nordisk A/S (Denmark)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Bristol Myers Squibb Company (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- AbbVie Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Amgen Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Takeda Pharmaceutical Company Limited (Japan)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Biogen Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Gilead Sciences, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Celgene Corporation (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Mylan N.V. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Teva Pharmaceutical Industries Ltd. (Israel)
Company Overview
Business Segment Overview
Financial Updates
Key Developments